|
Melanoma Clinical Trials- Recruiting |
Phase |
|
LC Bead Embolization Agent With Doxorubicin in the Treatment Liver Metastasis From Melanoma |
Phase 1 |
|
Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients |
Phase 3 |
|
Multicenter Selective Lymphadenectomy Trial II (MSLT-II) |
Phase 3 |
|
Evaluate Safety/Tolerability Intra-Arterial Temozolomide in Patients w/Extremity Melanoma by Isolated Limb Infusion |
Phase 1 |
|
Sample Collection From Melanoma Patients |
|
|
Sentinel Lymph Node (SLN) Biopsy for Conjunctival/Eyelid Melanoma |
Phase 1 |
|
Treatment With Dasatinib in Patients With Acral Lentiginous, Mucosal, or Chronic Sun-damaged Melanoma |
Phase 2 |
|
Open-Label Study of TPI 287 for Patients With Metastatic Melanoma |
Phase 1| Phase 2 |
|
IPI Biochemotherapy for Chemonaive Patients With Metastatic Melanoma |
Phase 1| Phase 2 |
|
Ipilimumab for Uveal Melanoma |
Phase 1| Phase 2 |
|
Doxycycline, Temozolomide and Ipilimumab in Melanoma |
Phase 1| Phase 2 |
|
A Phase I/II Study of TPI 287 – Temozolomide Combination in Melanoma |
Phase 1| Phase 2 |
|
Melanoma Gamma Knife |
Phase 3 |
|
Prospective Measurement of Post-Treatment Lymphedema |
|
|
Genasense, Carboplatin, Paclitaxel (GCP) Combination in Uveal Melanoma |
Phase 2 |
|
Nuclear and Near-Infrared (NIR) Imaging in Melanoma |
Phase 1 |
|
Safety and Efficacy Study of INGN 241 Gene Therapy in Patients With In Transit Melanoma |
Phase 2 |
|
Hepatic Arterial Infusion of Nab-Paclitaxel in Patients With Metastatic Melanoma in the Liver |
Phase 1 |
|
High-dose Interleukin-2 (HDIL-2), Combined With recMAGE-A3 + AS15 ASCI |
Phase 2 |
|
Study of Weekly LOC-paclitaxel Injection for Melanoma |
Phase 1 |
|
Tesetaxel as Second-line Therapy for Patients With Advanced Melanoma and Normal Serum LDH |
Phase 2 |
|
Lymphodepletion Plus Adoptive Cell Transfer With or Without Dendritic Cell Immunization |
Phase 2 |
|
Inflammatory Response and Tissue Fibrosis/ Lymphatico-venous Bypass |
|
|
Tumor and Vaccine Site With a Toll Like Receptor (TLR) Agonist |
Phase 2 |
|
Phase 1 Trial of ADI-PEG 20 Plus Cisplatin in Patients With Argininousccinate Synthetase Deficient Advanced Tumors |
Phase 1 |
|
Vemurafenib in Combination With Everolimus or Temsirolimus With Advanced Cancer |
Phase 1 |
|
Safety, Pharmacokinetics and Pharmacodynamics of BEZ235 Plus MEK162 in Selected Advanced Solid Tumor Patients |
Phase 1 |
|
Spinal Stereotactic Body Radiation Therapy |
|
|
Effectiveness of Using Biomarkers to Detect and Identify Cardiotoxicity and Describe Treatment (PREDICT) |
|
|
TEST: Registry for Endoscopic Head and Neck Surgery |
|
|
Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX) |
Phase 1 |
|
Evaluation of Sentinel Lymph Nodes in Head and Neck Squamous Cell Carcinoma |
Phase 3 |
|
A Phase II Study of Efficacy and Safety in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma |
Phase 2 |
|
Updated from clinicaltrials.gov on 9/08/2012 |
